Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-28T10:45:44.915Z Has data issue: false hasContentIssue false
  • English
  • Français

Predictive characteristics of methicillin-resistant Staphylococcus aureus nares screening tests for methicillin resistance among S. aureus clinical isolates from hospitalized veterans

Published online by Cambridge University Press:  15 April 2019

Teresa C. Fox Open the ORCID record for Teresa C. Fox [Opens in a new window] ,
Paul Thuras  and
James R. Johnson
Teresa C. Fox*
Affiliation:
Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota
Paul Thuras
Affiliation:
Department of Psychiatry, University of Minnesota, Minneapolis, Minnesota VA Mental Health Service Line, Minneapolis VA Medical Center, Minneapolis, Minnesota
James R. Johnson*
Affiliation:
Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota Infectious Diseases Section, Minneapolis VA Medical Center, Minneapolis, Minnesota
*
Author for correspondence: Teresa C. Fox, Email: [email protected] or James R. Johnson Email: [email protected]
Author for correspondence: Teresa C. Fox, Email: [email protected] or James R. Johnson Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Extract

For patients with possible Staphylococcus aureus infection, providers must decide whether to treat empirically for methicillin-resistant S. aureus (MRSA). Nares MRSA colonization screening tests could inform decisions regarding empiric MRSA-active antibiotic use.1,2

Type
Research Brief
Information
Infection Control & Hospital Epidemiology , Volume 40 , Issue 5 , May 2019 , pp. 603 - 605
Copyright
© 2019 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Previous Presentation: This work was presented in part at the IDSA IDWeek 2017 on October 4, 2017, in San Diego, California.

References

Smith, MN, Erdman, MJ, Ferreira, JA, Aldridge, P, Jankowski, CA. Clinical utility of methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction assay in critically ill patients with nosocomial pneumonia. J Crit Care 2017;38:168–171.CrossRefGoogle ScholarPubMed
Chotiprasitsakul, D, Tamma, PD, Gadala, A, Cosgrove, SE. The role of negative methicillin-resistant Staphylococcus aureus nasal surveillance swabs in predicting the need for empiric vancomycin therapy in intensive care unit patients. Infect Control Hosp Epidemiol 2018;39:290–296.CrossRefGoogle ScholarPubMed
Schleyer, AM, Jarman, KM, Chan, JD, Dellit, TH. Role of nasal methicillin-resistant Staphylococcus aureus screening in the management of skin and soft tissue infections. Am J Infect Control 2010;38:657–659.CrossRefGoogle ScholarPubMed
Dangerfield, B, Chung, A, Webb, B, Seville, MT. Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia. Antimicrob Agent Chemother 2014;58:859–864.CrossRefGoogle ScholarPubMed
Harris, AD, Furehabilitationno, JP, Roghmann, MC, et al. Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy. Antimicrob Agents Chemother 2010;54:3143–3148.CrossRefGoogle ScholarPubMed
Sarikonda, KV, Micek, ST, Doherty, JA, Reichley, RM, Warren, D, Kollef, MH. Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment. Crit Care Med 2010;38:1991–1995.CrossRefGoogle ScholarPubMed
Rimawi, RH, Ramsey, KM, Shah, KB, Cook, PP. Correlation between methicillin-resistant Staphylococcus aureus nasal sampling and S. aureus pneumonia in the medical intensive care unit. Infect Control Hosp Epidemiol 2014;35:590–593.CrossRefGoogle ScholarPubMed
MacFadden, DR, Elligsen, M, Robicsek, A, Ricciuto, DR, Daneman, N. Utility of prior screening for methicillin-resistant Staphylococcus aureus in predicting resistance of S. aureus infections. CMAJ 2013;185:E725–E730.CrossRefGoogle ScholarPubMed
Robicsek, A, Suseno, M, Beaumont, JL, Thomson, RB Jr., Peterson, LR. Prediction of methicillin-resistant Staphylococcus aureus involvement in disease sites by concomitant nasal sampling. J Clin Microbiol 2008;46:588–592.CrossRefGoogle ScholarPubMed
Parente, DM, Cunha, CB, Mylonakis, E, Timbrook, TT. The clinical utility of methicillin resistant Staphylococcus aureus (MRSA) nasal screening to rule out MRSA pneumonia: a diagnostic meta-analysis with antimicrobial stewardship implications. Clin Infect Dis 2018;67:1–7.CrossRefGoogle ScholarPubMed